USPTO serial 98340622
CLINICAL TRIALS BEYOND WALLS
Reviewed by CopyMark Law Group
Status 760
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMILLAN, CHRISTOPHER J
- Law office
- TMO LAW OFFICE 122
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CLINICAL TRIALS BEYOND WALLS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
TIMOTHY M. KENNY
Timothy M. Kenny Norton Rose Fulbright US LLP60 South Sixth Street, Suite 3100Minneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Specimen collection kits for the collection of saliva, blood, urine, stool, nasal or pulmonary secretions, nail clippings, and hair strands comprised primarily of swabs for medical purposes and also including cups, bags, boxes, tubes, vials, and slides | ACTIVE | — |
| 009 | Downloadable computer software for disease and health condition management including self-management, specifically for use to monitor and input information relating to disease and health conditions and for reporting information in the medical, healthcare and clinical research fields; downloadable computer software for disease and health condition management including self-management, specifically for use to monitor and input information relating to disease and health condition and for reporting information in the medical, healthcare and clinical research fields; downloadable computer application software for use on portable communications devices, namely, mobile phones, tablets, handheld computers, laptop computers, netbook computers, namely, software for disease and health condition management including self-management, specifically for use to monitor and input information relating to disease and health condition and for reporting information in the medical, healthcare and clinical research fields; downloadable computer software for use in developing and customizing computer software applications and computer software application user interfaces; downloadable computer software for entering, storing, managing, tracking, analyzing and reporting data and content in fields of personally identifiable information, health, well-being, fitness, sports, diet, energy usage, personal finance, customer feedback, employee efficiency and personal productivity; downloadable computer software for facilitating communication between individuals and organizations, companies or third parties in relation to data and content collected and stored within the software | ACTIVE | — |
| 010 | Anatomic pathology specimen collection kit, namely, kits for the collection of saliva, blood, urine, stool, nasal or pulmonary secretions, nail clippings, and hair strands comprising cups, bags, boxes, tubes, vials, and slides | ACTIVE | — |
| 035 | Business consulting and management in the field of clinical research, namely, recommending best practices for the implementation of decentralized capabilities; business advice related to the procurement and distribution of medical devices for clinical research and technology assessments and logistics workflows associated with the implementation of decentralized capabilities in clinical trials and remote care delivery services | ACTIVE | — |
| 041 | Production and distribution of videos in the field of educational content for clinical research teams and participants regarding telehealth capabilities and best practices, phone or video visits, remote monitoring, in-home nursing and paramedics evaluations, workflows to support patient safety when participating remotely, technology recommendations, vendor evaluation, change management, and adoption of decentralized capabilities into clinical research workflows | ACTIVE | — |
| 042 | Providing temporary use of online non-downloadable computer software for disease and health condition management including self-management, specifically for use to monitor and input information relating to disease and health conditions and for reporting information in the medical, healthcare and clinical research fields; providing temporary use of online non-downloadable computer application software for use on portable communications devices, namely, mobile phones, tablets, handheld computers, laptop computers, netbook computers, namely, software for disease and health condition management including self-management, specifically for use to monitor and input information relating to disease and health condition and for reporting information in the medical, healthcare and clinical research fields; providing temporary use of online non-downloadable computer software for entering, storing, managing, tracking, analyzing and reporting data and content in fields of personally identifiable information, health, well-being, fitness, sports, diet, energy usage, personal finance, customer feedback, employee efficiency and personal productivity; providing temporary use of online non-downloadable computer software for facilitating communication between individuals and organizations, companies or third parties in relation to data and content collected and stored within the software; Consulting services for others in the field of design, planning, and implementation project management of clinical research, namely, providing advice on clinical research design, protocol and consent language, storage and reporting methodology, participant expectations and considerations, and regulatory requirements; Conducting scientific research, clinical research for others relating to the development of digital biomarkers or endpoints to support improved patient care; Platform as a service (PAAS) featuring computer software platforms that permit users to identify, request and receive pharmacy products; Laboratory services and home health services, namely, medical testing for research purposes; Providing temporary use of on-line non-downloadable software for entering, storing, managing, tracking, analyzing and reporting data and content in the fields of personally identifiable information, health, well-being, fitness, sports, diet, educational development, energy usage, retail sales, customer feedback, employee efficiency and personal productivity; providing temporary use of on-line non-downloadable software for facilitating communication between individuals and organizations, companies or third parties in relation to data or content collected and stored within the software; computer services, namely, designing, developing, and maintaining computer software applications for others and consulting services related thereto; online hosted computer services, namely, designing, developing, customizing, and maintaining computer software applications for others and consulting services related thereto; Consulting services for others in the field of design, planning, and implementation project management of clinical research; Technical support services, namely, help desk services for IT infrastructure, operating systems, database systems, and web applications related to conducting of clinical research | ACTIVE | — |
| 044 | Providing medical information and health care services, namely, remote health care via the Internet or telecommunication networks; Remote monitoring of medical data for medical diagnosis and treatment; Remote phlebotomy services; Medical services, namely, intravenous (IV) infusion services; Laboratory services, namely, medical testing for diagnostic or treatment purposes; Providing educational information about healthcare for clinical research teams and participants regarding telehealth capabilities and best practices, phone and video visits, remote monitoring, in-home nursing and paramedics evaluations, workflows to support patient safety when participating remotely, technology recommendations, vendor evaluation, change management, and adoption of decentralized capabilities into clinical research workflows | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mayo Foundation for Medical Education and Research
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CLINICAL TRIALS BEYOND WALLS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 4, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 4, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 4, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 4, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 23, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 23, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 4, 2026 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| May 4, 2026 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| May 4, 2026 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| May 3, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 13, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 13, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 13, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 8, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 8, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 8, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 7, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 7, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 10, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 10, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 10, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 4, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Dec 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 3, 2024 | NWAP | NEW APPLICATION ENTERED | — |